2,2-bis(4-glycidyloxyphenyl)propane has been researched along with rosiglitazone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clish, CB; Hauser, S; Hiramatsu, R; Mikami, T; Serhan, CN; Spiegelman, BM; Wright, HM; Yanagi, K | 1 |
| Akanuma, Y; Ezaki, O; Fukayama, M; Hori, W; Ide, T; Itai, A; Kadowaki, T; Kagechika, H; Kamon, J; Kato, S; Kimura, S; Komeda, K; Kubota, N; Miki, H; Motojima, K; Murakami, K; Nagai, R; Shudo, K; Terauchi, Y; Tobe, K; Tsuboyama-Kasaoka, N; Tsuchida, A; Waki, H; Yamauchi, N; Yamauchi, T | 1 |
| Caputi, AP; Chatterjee, PK; Cuzzocrea, S; Di Paola, R; Di Rosa, M; Dugo, L; Genovese, T; Ianaro, A; Patel, NS; Pisano, B; Thiemermann, C | 1 |
| Caputi, AP; Catalano, P; Crimi, N; Cuzzocrea, S; Di Paola, R; Genovese, T; Mastruzzo, C; Mazzon, E; Sortino, M; Thiemermann, C; Vancheri, C | 1 |
| Balaguer, P; Carlavan, I; Lemaire, G; Nicolas, JC; Perrin, A; Pillon, A; Seimandi, M; Vignon, F; Voegel, JJ | 1 |
| Ahn, JH; Cheon, HG; Kim, KY | 1 |
| Abdel-Aleem, OS; Churi, SB; Scuderi-Porter, H; Taylor, BK; Tumber, KK | 1 |
| Belury, MA; DeIuliis, J; Koba, K; Lee, K; Liu, LF; Purushotham, A; Wendel, AA | 1 |
| Ding, B; Hou, Y; Liu, Y; Lu, J; Meng, G; Shi, J; Yin, Y; Zhao, S; Zhu, H | 1 |
| Abdel-Aleem, OS; Badr, MZ; Donahue, RR; McNamara, KC; Morgenweck, J; Taylor, BK | 1 |
| Carluccio, MA; De Caterina, R; Distante, A; Massaro, M; Scoditti, E; Storelli, C | 1 |
| Celinski, K; Cichoz-Lach, H; Czechowska, G; Dworzanski, T; Korolczuk, A; Madro, A; Radej, S; Slomka, M | 1 |
| Celinski, K; Dworzanski, T; Fornal, R; Korolczuk, A; Madro, A; Piasecki, R; Slomka, M | 1 |
| Hou, G; Kang, J; Li, ER; Wang, QY; Yin, Y | 1 |
14 other study(ies) available for 2,2-bis(4-glycidyloxyphenyl)propane and rosiglitazone
| Article | Year |
|---|---|
A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation.
Topics: 1-Methyl-3-isobutylxanthine; 3T3 Cells; Adipocytes; Animals; Benzhydryl Compounds; Cell Differentiation; Cell Nucleus; Chromatography, High Pressure Liquid; Dexamethasone; Dose-Response Relationship, Drug; Epoxy Compounds; Gas Chromatography-Mass Spectrometry; Glucocorticoids; Hypoglycemic Agents; Insulin; Ligands; Mice; Phosphodiesterase Inhibitors; Protein Binding; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic | 2000 |
Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes.
Topics: 3T3 Cells; Adipose Tissue; Animals; Benzhydryl Compounds; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Epoxy Compounds; Fatty Acids; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Leptin; Mice; Mice, Knockout; Nicotinic Acids; Obesity; Receptors, Adrenergic, beta-3; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors | 2001 |
Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Topics: Animals; Benzhydryl Compounds; Blood Pressure; Epoxy Compounds; Immunologic Factors; Intercellular Adhesion Molecule-1; Interleukin-1; Intestinal Mucosa; Intestines; Ligands; Male; Malondialdehyde; Peroxidase; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha; Tyrosine; Vasodilator Agents | 2003 |
Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury.
Topics: Analysis of Variance; Animals; Benzhydryl Compounds; Biopsy; Bleomycin; Epoxy Compounds; Immunoenzyme Techniques; Instillation, Drug; Male; Mice; Nitric Oxide Synthase; Peroxidase; Poly(ADP-ribose) Polymerases; Prostaglandin D2; Pulmonary Fibrosis; Random Allocation; Rosiglitazone; Thiazolidinediones; Tyrosine; Weight Loss | 2005 |
Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands.
Topics: Anilides; Benzhydryl Compounds; Butyrates; DNA-Binding Proteins; Epoxy Compounds; Genes, Reporter; HeLa Cells; Humans; Inhibitory Concentration 50; Ligands; Luciferases; Peroxisome Proliferator-Activated Receptors; Phenylurea Compounds; PPAR alpha; PPAR delta; PPAR gamma; Rosiglitazone; Saccharomyces cerevisiae Proteins; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection | 2005 |
Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
Topics: Apoptosis; Benzhydryl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Epoxy Compounds; Formazans; Humans; Indenes; Lung Neoplasms; Morpholines; PPAR gamma; Proline Oxidase; Reactive Oxygen Species; RNA Interference; Rosiglitazone; Tetrazolium Salts; Thiazolidinediones | 2007 |
Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats.
Topics: Animals; Behavior, Animal; Benzhydryl Compounds; Blotting, Western; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Epoxy Compounds; Gene Expression; Injections, Intraventricular; Injections, Spinal; Male; Motor Activity; Neuralgia; PPAR gamma; Prostaglandin D2; Protein Binding; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Sciatic Nerve; Spinal Cord; Thiazolidinediones | 2008 |
Regulation of adipose triglyceride lipase by rosiglitazone.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Benzhydryl Compounds; Blood Glucose; Carboxylic Ester Hydrolases; Cell Differentiation; Diacylglycerol O-Acyltransferase; Epoxy Compounds; Hypoglycemic Agents; Immunohistochemistry; Lipase; Male; Mice; Mice, Inbred C57BL; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2009 |
Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge.
Topics: Animals; Benzhydryl Compounds; Cytokines; Dimethyl Sulfoxide; Dinoprostone; Epoxy Compounds; Escherichia coli; Free Radical Scavengers; Hydrocortisone; Inflammation; Insulin-Like Growth Factor I; Interleukin-6; Lipopolysaccharides; Male; PPAR gamma; Rosiglitazone; Swine; Thiazolidinediones; Tumor Necrosis Factor-alpha; Weaning | 2009 |
Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.
Topics: Anilides; Animals; Benzhydryl Compounds; Brain; Central Nervous System Agents; Disease Models, Animal; Edema; Epoxy Compounds; Gene Expression; Inflammation; Male; Pain; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spinal Cord; Thiazolidinediones | 2010 |
PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
Topics: Angiogenesis Inhibitors; Anilides; Benzhydryl Compounds; Benzophenones; Binding Sites; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Down-Regulation; Endothelial Cells; Epoxy Compounds; Gene Expression Regulation, Enzymologic; Humans; Neovascularization, Physiologic; Nitrobenzenes; PPAR gamma; Promoter Regions, Genetic; Protein Kinase C-alpha; Protein Transport; RNA Interference; RNA, Messenger; Rosiglitazone; Sulfonamides; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transfection; Tyrosine; Vascular Endothelial Growth Factor A | 2010 |
Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
Topics: Animals; Benzhydryl Compounds; Colitis; Cytokines; Epoxy Compounds; Intestine, Large; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2010 |
Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
Topics: Animals; Behavior, Animal; Benzhydryl Compounds; Carcinogens; Colitis; Colon; Cytokines; Dextran Sulfate; Epoxy Compounds; Hypoglycemic Agents; Intestinal Mucosa; Intestine, Large; Ligands; Peroxidase; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2011 |
Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
Topics: Animals; Benzhydryl Compounds; Bronchi; Cell Survival; Cells, Cultured; Disease Models, Animal; Down-Regulation; Epithelial Cells; Epoxy Compounds; In Vitro Techniques; Interleukin-8; Leukotriene B4; Male; NF-kappa B; Pneumonia; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Smoking; Thiazolidinediones; Toll-Like Receptor 4; Up-Regulation | 2013 |